108 related articles for article (PubMed ID: 28002035)
1. The Effect of Omega-3 Supplement on Serum Lipid Profile in Patients Undergoing Hemodialysis: A Randomized Clinical Trial.
Jabbari M; Khoshnevis T; Jenabi A; Yousefi F
Rom J Intern Med; 2016 Dec; 54(4):222-227. PubMed ID: 28002035
[TBL] [Abstract][Full Text] [Related]
2. Effects of omega-3 fatty acids on serum lipids, lipoprotein (a), and hematologic factors in hemodialysis patients.
Kooshki A; Taleban FA; Tabibi H; Hedayati M
Ren Fail; 2011; 33(9):892-8. PubMed ID: 21859401
[TBL] [Abstract][Full Text] [Related]
3. Potential Effects of Omega-3 Fatty Acids on Insulin Resistance and Lipid Profile in Maintenance Hemodialysis Patients: a Randomized Placebo-Controlled Trial.
Gharekhani A; Dashti-Khavidaki S; Lessan-Pezeshki M; Khatami MR
Iran J Kidney Dis; 2016 Sep; 10(5):310-318. PubMed ID: 27721230
[TBL] [Abstract][Full Text] [Related]
4. Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients.
Tayyebi-Khosroshahi H; Houshyar J; Dehgan-Hesari R; Alikhah H; Vatankhah AM; Safaeian AR; Zonouz NR
Saudi J Kidney Dis Transpl; 2012 May; 23(3):500-6. PubMed ID: 22569435
[TBL] [Abstract][Full Text] [Related]
5. Effect of Omega-3 Fatty Acids on Serum Lipid Profile and Oxidative Stress in Pediatric Patients on Regular Hemodialysis: A Randomized Placebo-Controlled Study.
Ateya AM; Sabri NA; El Hakim I; Shaheen SM
J Ren Nutr; 2017 May; 27(3):169-174. PubMed ID: 28110812
[TBL] [Abstract][Full Text] [Related]
6. Effect of omega-3 supplementation on serum level of homocysteine in hemodialysis patients.
Tayebi-Khosroshahi H; Dehgan R; Habibi Asl B; Safaian A; Panahi F; Estakhri R; Purasgar B
Iran J Kidney Dis; 2013 Nov; 7(6):479-84. PubMed ID: 24241095
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acid supplementation on lipid profiles in dialysis patients: meta-analysis.
Chi H; Lin X; Huang H; Zheng X; Li T; Zou Y
Arch Med Res; 2014 Aug; 45(6):469-77. PubMed ID: 25010561
[TBL] [Abstract][Full Text] [Related]
8. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
Hobbs T; Caso R; McMahon D; Nymark M
Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
[TBL] [Abstract][Full Text] [Related]
9. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
[TBL] [Abstract][Full Text] [Related]
10. A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes.
Taghizadeh M; Jamilian M; Mazloomi M; Sanami M; Asemi Z
J Clin Lipidol; 2016; 10(2):386-93. PubMed ID: 27055970
[TBL] [Abstract][Full Text] [Related]
11. Effects of Omega-3 Fatty Acid Supplementation on Serum Biomarkers, Inflammatory Agents, and Quality of Life of Patients on Hemodialysis.
Moeinzadeh F; Shahidi S; Mortazavi M; Dolatkhah S; Kajbaf M; Haghjooy Javanmard S; Moghtaderi A
Iran J Kidney Dis; 2016 Nov; 10(6):381-387. PubMed ID: 27903997
[TBL] [Abstract][Full Text] [Related]
12. Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients.
Hassan KS; Hassan SK; Hijazi EG; Khazim KO
Ren Fail; 2010; 32(9):1031-5. PubMed ID: 20863205
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-I, apo B, and malondialdehyde in hyperlipidemic patients.
Shidfar F; Keshavarz A; Jallali M; Miri R; Eshraghian M
Int J Vitam Nutr Res; 2003 May; 73(3):163-70. PubMed ID: 12847992
[TBL] [Abstract][Full Text] [Related]
14. Effect of zinc supplementation on triglyceride, cholesterol, LDL, and HDL levels in zinc-deficient hemodialysis patients.
Roozbeh J; Hedayati P; Sagheb MM; Sharifian M; Hamidian Jahromi A; Shaabani S; Jalaeian H; Raeisjalali GA; Behzadi S
Ren Fail; 2009; 31(9):798-801. PubMed ID: 19925287
[TBL] [Abstract][Full Text] [Related]
15. Fish oil treatment of hyperlipidemia in children and adolescents receiving renal replacement therapy.
Goren A; Stankiewicz H; Goldstein R; Drukker A
Pediatrics; 1991 Aug; 88(2):265-8. PubMed ID: 1861924
[TBL] [Abstract][Full Text] [Related]
16. Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress, and serum lipid profile levels in patients with end-stage renal disease on hemodialysis.
Khabbazi T; Mahdavi R; Safa J; Pour-Abdollahi P
J Ren Nutr; 2012 Mar; 22(2):244-250. PubMed ID: 21908204
[TBL] [Abstract][Full Text] [Related]
17. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
Chevalier CA; Liepa G; Murphy MD; Suneson J; Vanbeber AD; Gorman MA; Cochran C
J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
[TBL] [Abstract][Full Text] [Related]
18. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients.
An WS; Kim SE; Kim KH; Lee S; Park Y; Kim HJ; Vaziri ND
J Ren Nutr; 2009 Jul; 19(4):267-74. PubMed ID: 19539181
[TBL] [Abstract][Full Text] [Related]
19. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
20. Oral carnitine supplementation for dyslipidemia in chronic hemodialysis patients.
Naini AE; Sadeghi M; Mortazavi M; Moghadasi M; Harandi AA
Saudi J Kidney Dis Transpl; 2012 May; 23(3):484-8. PubMed ID: 22569432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
